Pharma & Biotech

A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry

The pharmaceutical industry’s commercial trade function is undergoing a fundamental transformation, driven by mounting policy pressures and the growing complexity of specialty therapies. Regulatory frameworks including the 340B drug pricing programme and

Pharmaceutical companies that negotiate behind-the-scenes deals with pharmacy benefit managers are now facing scrutiny they did not anticipate when the rule was first proposed. The Department of Labour’s new PBM disclosure rule

The gap between how large pharmaceutical companies and emerging biotechs bring products to market has widened into two fundamentally distinct strategic playbooks. Jon Hamrick, a partner at Curatio Advisors, argues that the

Two of the pharmaceutical and healthcare sector’s biggest names are weighing structural changes that could reshape how medicines are priced and distributed across the industry. CVS Health, one of the largest integrated

The pharmaceutical industry’s long reliance on static dashboards to manage supply chain complexity may be approaching its end, according to a leading visibility technology executive. Mark Talens of PAXAFE made the case

Pharmaceutical supply chains are facing a growing security threat, not just from opportunistic theft but from increasingly sophisticated diversion strategies targeting outbound freight. Industry experts are warning that a persistent culture of

A federal healthcare programme is racing toward a hard deadline with a lawsuit, a congressional bill, and drugmaker legal motions all threatening to derail it. HRSA’s 340B rebate pilot, designed to reshape

Pharmaceutical companies risk wasting significant resources by rushing into artificial intelligence deployments without first establishing a coherent agent strategy, according to senior Cencora leaders. Matt Sample and Gregg Gorniak, both executives at

CSafe took centre stage at LogiPharma USA 2026, addressing one of the pharmaceutical cold chain industry’s most persistent challenges: right-sizing bulk air cargo protection. The event brought together leading voices in pharma